Related references
Note: Only part of the references are listed.Hepatobiliary Cancer Risk in Patients with Inflammatory Bowel Disease: A Scandinavian Population-Based Cohort Study
Rune Erichsen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)
Epidemiology of Inflammatory Bowel Diseases in Israel: A Nationwide Epi-Israeli IBD Research Nucleus Study
Mira Y. Stulman et al.
INFLAMMATORY BOWEL DISEASES (2021)
Role of Thiopurines in Pediatric Inflammatory Bowel Diseases: A Real-Life Prospective Cohort Study
Ohad Atia et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2020)
Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study
Ola Olen et al.
LANCET (2020)
Colorectal cancer in Crohn's disease: a Scandinavian population-based cohort study
Ola Olen et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Inflammatory bowel disease and pancreatic cancer: a Scandinavian register-based cohort study 1969-2017
Asa H. Everhov et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Cancer Risk in Pediatric-Onset Inflammatory Bowel Disease: A Population-Based Danish Cohort Study
Victoria S. Kjaergaard et al.
GASTROENTEROLOGY (2020)
The incidence of cancer and mortality in paediatric onset inflammatory bowel disease in Denmark and Finland during a 23-year period: a population-based study
Mikkel Malham et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Malignancy and mortality in paediatric-onset inflammatory bowel disease: a 3-year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN
M. E. Joosse et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Malignancy and Mortality in Pediatric-onset Inflammatory Bowel Disease: A Systematic Review
Martine A. Aardoom et al.
INFLAMMATORY BOWEL DISEASES (2018)
Development and validation of novel algorithms to identify patients with inflammatory bowel diseases in Israel: an epi-IIRN group study
Mira Y. Friedman et al.
CLINICAL EPIDEMIOLOGY (2018)
Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease
Jeffrey S. Hyams et al.
GASTROENTEROLOGY (2017)
Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease
Magali Lemaitre et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Long-term outcomes of pediatric inflammatory bowel disease
Soheila Nasiri et al.
SEMINARS IN PEDIATRIC SURGERY (2017)
Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014
O. Olen et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014
O. Olen et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Are Patients with Inflammatory Bowel Disease on Chronic Immunosuppressive Therapy at Increased Risk of Cervical High-grade Dysplasia/Cancer? A Meta-analysis
Jessica R. Allegretti et al.
INFLAMMATORY BOWEL DISEASES (2015)
Presentation and Progression of Childhood-Onset Inflammatory Bowel Disease in Northern Stockholm County
Petter Malmborg et al.
INFLAMMATORY BOWEL DISEASES (2015)
Risk of Cancer in Patients With Inflammatory Bowel Diseases: A Nationwide Population-based Cohort Study With 30 Years of Follow-up Evaluation
Michael D. Kappelman et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Malignancy and Mortality in Pediatric Patients with Inflammatory Bowel Disease: A Multinational Study from the Porto Pediatric IBD Group
Lissy de Ridder et al.
INFLAMMATORY BOWEL DISEASES (2014)
Cancer Risk in Inflammatory Bowel Disease According to Patient Phenotype and Treatment: A Danish Population-Based Cohort Study
Tine Jess et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Risk of Melanoma and Nonmelanoma Skin Cancer Among Patients With Inflammatory Bowel Disease
Millie D. Long et al.
GASTROENTEROLOGY (2012)
Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease
Fiona D. M. van Schaik et al.
GUT (2012)
Lymphoma risk in children and young adults with inflammatory bowel disease: Analysis of a large single-center cohort
Lori A. Ashworth et al.
INFLAMMATORY BOWEL DISEASES (2012)
Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease
Laurent Peyrin-Biroulet et al.
GUT (2011)
Increased Risk for Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel Disease
Millie D. Long et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Natural History of Crohn's Disease: Comparison Between Childhood- and Adult-Onset Disease
Benedicte Pigneur et al.
INFLAMMATORY BOWEL DISEASES (2010)
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
Laurent Beaugerie et al.
LANCET (2009)
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine
A Kandiel et al.
GUT (2005)
Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark
T Jess et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine
GA Dayharsh et al.
GASTROENTEROLOGY (2002)
Why do we continue to use standardized mortality ratios for small area comparisons?
SA Julious et al.
JOURNAL OF PUBLIC HEALTH MEDICINE (2001)
Share Paper
